Encompass Health Corp (EHC)

NYSE · Healthcare · Medical Care Facilities · USA

Encompass Health Corp is a large cap company (market value between $10 billion and $200 billion) in the Medical Care Facilities industry.

Encompass Health operates inpatient rehabilitation hospitals providing specialized care to patients recovering from major injuries or illnesses. The company delivers intensive therapy and advanced technology treatment, with most admissions from acute-care hospitals. Encompass Health is the largest operator of inpatient rehabilitation hospitals by patient volume and hospital count.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Encompass Health Corp stock.

Our verdict on EHC

Fairly valued: intrinsic value $139.11 per share, market price $135.90, margin of safety 2.3% (as of 2026-10-30).

Discounting its cash flows at 8.9% (average of 3 methods) values the shares at $139.11; the price of $135.90 is 2% below that value, and 77% of that value comes from beyond year five.

Leak Score: 56/100 on 11 of 12 signals (Weak Signal).

ETFs with the most weight in EHC

17 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Compare side by side

Cheaper than EHC in Medical Care Facilities

10 more in this industry show a wider margin of safety.

Is EHC undervalued or overvalued?

EHC is fairly valued (as of the 2026-10-30 close). Discounting its cash flows at 8.9% (average of 3 methods) values the shares at $139.11; the price of $135.90 is 2% below that value, and 77% of that value comes from beyond year five.

What is the intrinsic value of EHC?

$139.11 per share (as of the 2026-10-30 close), against a market price of $135.90. That is a margin of safety of 2.3%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is Encompass Health Corp's Leak Score?

56 out of 100, which we rate "Weak Signal", on 11 of 12 value investing signals.